Calendar
Groups
Print Newsletters
Donate to PRO!March 1, 2023
ICBII Update on the Road to the Cure - March 2023
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer RISKS OF STEM CELL TRANSPLANT THERAPY FOR PARKINSON'S DISEASE On February 9, 2023, Magenta Therapeutics reported...
Read More
February 1, 2023
ICBII Update on the Road to the Cure - February 2023
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer STEM CELL THERAPY FOR PARKINSON'S DISEASE There has been a lot of talk recently on social...
December 1, 2022
ICBII Update on the Road to the Cure - December 2022
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer EFFORTS TOWARDS A PARKINSON’S CURE The cure of any disease, including Parkinson’s, depends upon two key...
November 1, 2022
ICBII Update on the Road to the Cure - November 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer Fibroblast Growth Factor 1 (FGF-1) - Scientists at Zhittya Genesis Medicine are looking at fibroblast...
September 1, 2022
Message from the President - September 2022
September is a very important month for me, for many reasons. Perhaps the largest is that this year marks seven years with a clean...
September 1, 2022
ICBII Update on the Road to the Cure - September 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer In the August 2022 Newsletter we described that in most neurodegenerative diseases, including Parkinson’s, myelin...
July 28, 2022
Message from the President - August 2022
August is here, and with it the dog days of summer. Hot days and slowly lengthening nights—the imperative is to slow down, soak up...
July 28, 2022
ICBII Update on the Road to the Cure - August 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer Last month, we discussed whether stem-cell therapy can produce dopamine producing neurons in the brain...
June 30, 2022
ICBII Update on the Road to the Cure - July 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer The Role of LRRK2 in Parkinson’s disease – Mutations in the leucine-rich repeat kinase 2...
May 31, 2022
ICBII Update on the Road to the Cure - June 2022
CHANGES IN VOICE MAY BE AN EARLY INDICATION OF PARKINSON’S DISEASE Parkinson’s disease, best known for its movement-related symptoms, particularly tremors and stiffness, is also known...
April 28, 2022
President's Message (May 2022)
MAY you always be the happiest person you can be through the breezes and tides; May carries with it a second chance. The month...
April 28, 2022
ICBII UPDATE ON THE ROAD TO THE CURE (May 2022)
Solving the Blood-Brain Barrier Conundrum in CNS Drug Development Last month’s editorial remarks by Jo Rosen being reprinted: in 1998 I was told by Robert...
December 29, 2021
Update on the Road to the Cure - January 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer ICBII is named among big pharma developing technology to cross the BBB Parkinson’s Cure May Be Closer...
September 1, 2021
Recent Developments in the Treatment of Parkinson’s Disease
ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer Recent Developments in the Treatment of Parkinson’s — Considering the global...
August 1, 2021
Message from the President - August 2021
PRESIDENT’S MESSAGE August already… where has the summer gone? As we enjoy our hot desert summer temperatures, we hope your “lazy days” are filled with...
